ES2102371T3 - 3h,6h-1,4,5a,8a-tetraazaacenaftilen-3,5(4h)-dionas. - Google Patents

3h,6h-1,4,5a,8a-tetraazaacenaftilen-3,5(4h)-dionas.

Info

Publication number
ES2102371T3
ES2102371T3 ES91100189T ES91100189T ES2102371T3 ES 2102371 T3 ES2102371 T3 ES 2102371T3 ES 91100189 T ES91100189 T ES 91100189T ES 91100189 T ES91100189 T ES 91100189T ES 2102371 T3 ES2102371 T3 ES 2102371T3
Authority
ES
Spain
Prior art keywords
dionas
tetraazaacenaftilen
tetraazaacenaftileno
auxiolytics
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91100189T
Other languages
English (en)
Spanish (es)
Inventor
Shin Shyong Tseng
Joseph William Epstein
Jeremy Ian Levin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2102371T3 publication Critical patent/ES2102371T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES91100189T 1990-02-21 1991-01-08 3h,6h-1,4,5a,8a-tetraazaacenaftilen-3,5(4h)-dionas. Expired - Lifetime ES2102371T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/482,568 US5013737A (en) 1988-02-22 1990-02-21 2,4,8-Trisubstituted-3H,6H-1,4,5A,8A-tetraazaacenaphtylene-3,5-(4H)-diones and 2,4-8-trisubstituted-4,5-dihydro-5-thioxo-3H,6H-1,4,5A,8A-tetrazaacenaphthylen-3-ones

Publications (1)

Publication Number Publication Date
ES2102371T3 true ES2102371T3 (es) 1997-08-01

Family

ID=23916572

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91100189T Expired - Lifetime ES2102371T3 (es) 1990-02-21 1991-01-08 3h,6h-1,4,5a,8a-tetraazaacenaftilen-3,5(4h)-dionas.

Country Status (24)

Country Link
US (1) US5013737A (da)
EP (1) EP0443312B1 (da)
JP (1) JP3046851B2 (da)
KR (1) KR0183395B1 (da)
AT (1) ATE152723T1 (da)
AU (1) AU640202B2 (da)
CA (1) CA2036589A1 (da)
CZ (1) CZ285584B6 (da)
DE (1) DE69125962T2 (da)
DK (1) DK0443312T3 (da)
ES (1) ES2102371T3 (da)
FI (1) FI93963C (da)
GR (1) GR3024063T3 (da)
HU (1) HUT60500A (da)
IE (1) IE910575A1 (da)
IL (1) IL97289A (da)
NO (1) NO177749C (da)
NZ (1) NZ237123A (da)
PH (1) PH27464A (da)
PL (1) PL166100B1 (da)
PT (1) PT96805B (da)
SG (1) SG47638A1 (da)
SK (1) SK279997B6 (da)
ZA (1) ZA911260B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1129091E (pt) * 1998-11-12 2003-02-28 Neurocrine Biosciences Inc Antagonistas de receptor de crf e metodos relacionados
PT1129096E (pt) * 1998-11-12 2003-09-30 Neurocrine Biosciences Inc Antagonistas de receptor de crf e metodos de tratamento relacionados com os mesmos
MX2008011853A (es) * 2006-03-17 2008-09-29 Wyeth Corp Derivados de pirazolo[1,5-a]pirimidina y sus metodos de uso.
US20070219183A1 (en) * 2006-03-17 2007-09-20 Wyeth Dihydropyrazolo[1,5-A]pyrimidine and dihydroimidazo[1,5-A]pyrimidine derivatives and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178449A (en) * 1978-04-17 1979-12-11 American Cyanamid Company Pyrazolo[1,5-a]pyrimidines and imidazo-[1,5-a]pyrimidines
US4236005A (en) * 1979-07-02 1980-11-25 American Cyanamid Company Imidazo[1,5-a]pyrimidines
US4281000A (en) * 1979-07-09 1981-07-28 American Cyanamid Company Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents
US4713383A (en) * 1984-10-01 1987-12-15 Ciba-Geigy Corporation Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
US4614732A (en) * 1984-10-26 1986-09-30 Warner-Lambert Company N6 -acenaphthyl adenosines and analogs thereof
ATE99686T1 (de) * 1988-02-22 1994-01-15 American Cyanamid Co 5-(substituierte amino)-8-(phenyl oder substituierte phenyl)-3h,6h-1,4,5a,8atetraazaacenaphthylen-3-one.

Also Published As

Publication number Publication date
US5013737A (en) 1991-05-07
JP3046851B2 (ja) 2000-05-29
PL166100B1 (pl) 1995-03-31
EP0443312A3 (en) 1992-02-19
HU910584D0 (en) 1991-09-30
NO177749C (no) 1995-11-15
PL289157A1 (en) 1992-06-26
FI93963B (fi) 1995-03-15
KR0183395B1 (ko) 1999-05-01
JPH04211086A (ja) 1992-08-03
EP0443312A2 (en) 1991-08-28
NZ237123A (en) 1994-07-26
ZA911260B (en) 1992-10-28
ATE152723T1 (de) 1997-05-15
PH27464A (en) 1993-07-09
FI910816A0 (fi) 1991-02-20
EP0443312B1 (en) 1997-05-07
PT96805B (pt) 1998-07-31
HUT60500A (en) 1992-09-28
AU7122591A (en) 1991-08-22
SK279997B6 (sk) 1999-06-11
NO177749B (no) 1995-08-07
DK0443312T3 (da) 1997-11-17
GR3024063T3 (en) 1997-10-31
DE69125962D1 (de) 1997-06-12
FI93963C (fi) 1995-06-26
NO910686D0 (no) 1991-02-20
IL97289A0 (en) 1992-05-25
CZ285584B6 (cs) 1999-09-15
IE910575A1 (en) 1991-08-28
CS41991A3 (en) 1991-09-15
IL97289A (en) 1995-06-29
NO910686L (no) 1991-08-22
AU640202B2 (en) 1993-08-19
PT96805A (pt) 1991-10-31
CA2036589A1 (en) 1991-08-22
FI910816L (fi) 1991-08-22
SG47638A1 (en) 1998-04-17
DE69125962T2 (de) 1997-10-16

Similar Documents

Publication Publication Date Title
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
ATE133181T1 (de) Dehydrodidemnin b
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ES2124479T3 (es) Composiciones biocidas.
DE69637625D1 (de) Methoden und zusammensetzungen, die das ueberleben und die funktion von keimbahnzellen und embryonen verbessern
ES2017611T3 (es) Tiazoles sustituidos y su uso como fungicidas.
ES2106965T3 (es) Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
GT199600026A (es) Isotiazolonas
GT199900158A (es) "combinaciones para la diabetes"
CU22869A3 (es) 1-aril-pirazoles plaguicidas
DE69111077D1 (de) Chinazolinderivate um die antitumorwirkung zu verbessern.
ES2067945T3 (es) Derivados de hidroxiurea hipoglicemica.
TR199701212T1 (xx) �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�.
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
ES2071169T3 (es) 1-indolilalquil-4-(alcoxi-pirimidinil)piperazinas.
ES2054944T3 (es) Bis-(tri-t-alquilfenoxi) difosfaespiroundecanos.
ES2120762T3 (es) Nuevas composiciones herbicidas.
MY105128A (en) Bu-3608 derivatives.
ES2102371T3 (es) 3h,6h-1,4,5a,8a-tetraazaacenaftilen-3,5(4h)-dionas.
ES2029799T3 (es) Derivados de 2,5,6,7 tetranor-4,8-inter-m-fenilen pg12.
TR199900430T2 (xx) �kameli 1,2,3,4-tetrahidro-2-dibenzofuranaminler ve 2-aminosiklohepta$b] benzofuranlar.
ATE45739T1 (de) Indolophenanthridine, ihre herstellung und verwendung.
ES2059396T3 (es) Derivados de indeno y metodos.
ES2077891T3 (es) Empleo de oximeter derivados para la biorregulacion de las plantas.
ES2166045T3 (es) Procedimiento para la preparacion de compuestos de 4,6-bis(ariloxi)pirimidina asimetricos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 443312

Country of ref document: ES